QuidelOrtho Corporation (QDEL) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

QuidelOrtho Corporation (QDEL)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

41.14

-3.47 (-7.78%)

At close: Jan 14, 2025, 3:59 PM

41.10

-0.10%

After-hours Jan 14, 2025, 04:00 PM EST

undefined% (undefined)

Bid	40.17
Market Cap	2.77B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-27.81
PE Ratio (ttm)	-1.48
Forward PE	n/a
Analyst	Hold

Ask	48
Volume	1,407,962
Avg. Volume (20D)	915,977
Open	45.11
Previous Close	44.61
Day's Range	40.10 - 45.11
52-Week Range	29.74 - 74.04
Beta	undefined

About QDEL

QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical managem...

[Show more]

Industry Medical - Instruments & Supplies

Sector Healthcare

IPO Date Feb 1, 1991

Employees 7,100

Stock Exchange NASDAQ

Ticker Symbol QDEL

Website https://www.quidelortho.com

Analyst Forecast

According to 8 analyst ratings, the average rating for QDEL stock is "Hold." The 12-month stock price forecast is $50, which is an increase of 21.54% from the latest price.

Buy 37.50%

Hold 50.00%

Sell 12.50%

Stock Forecasts

Next Earnings Release

QuidelOrtho Corporation is scheduled to release its earnings on Feb 12, 2025, after market closes.
Analysts project revenue of $698.04M, reflecting a -6% YoY shrinking and earnings per share of 0.57, making a -51.28% decrease YoY.

Why Price Moved

1 month ago · Source

+7.84%

QuidelOrtho shares are trading higher after Citigr... Unlock content with Pro Subscription

2 months ago · Source

-2.78%

QuidelOrtho shares are trading higher after the company reported better-than-expected Q3 financial results and issued FY24 revenue above estimates.

News

1 day ago · zacks.com

QuidelOrtho Stock Down Despite Solid Preliminary Q4 Revenues

QDEL's preliminary fourth-quarter revenues align with the company's expectations.

2 weeks ago · businesswire.com

QuidelOrtho to Present at the 43rd Annual J.P. Morgan Healthcare Conference

SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care settings, clinical labs ...

1 month ago · businesswire.com

QuidelOrtho Announces Appointment of Two Independent Directors to its Board

SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care setting...

1 month ago · zacks.com

Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now

QDEL continues to witness growth on the back of its strong product portfolio.

1 month ago · benzinga.com

Carlyle Sells QuidelOrtho Shares, Analyst Sees Overhang Lifted

On Tuesday, QuidelOrtho Corporation QDEL priced the previously announced underwritten secondary offering by Carlyle Partners VI Cayman Holdings of 8.26 million shares.

1 month ago · benzinga.com

Powell Industries Reports Weak Sales, Joins Target, QuidelOrtho And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

U.S. stock futures were higher this morning, with the Dow futures gaining around 0.2% on Wednesday.

1 month ago · businesswire.com

QuidelOrtho Corporation Announces Pricing of Secondary Offering of Common Stock by the Carlyle Group

SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settin...

1 month ago · businesswire.com

QuidelOrtho Corporation Announces Secondary Offering of Common Stock by the Carlyle Group

2 months ago · zacks.com

QuidelOrtho Stock Rises as Q3 Earnings & Revenues Beat Estimates

QDEL's third-quarter results reflect growth in non-respiratory revenues along with a lowering of operating expenses year over year. However, the gross margin declines in the reported quarter.

2 months ago · seekingalpha.com

QuidelOrtho Corporation (QDEL) Q3 2024 Earnings Call Transcript

QuidelOrtho Corporation (NASDAQ:QDEL ) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Juliet Cunningham – Vice President, Investor Relations Brian Blaser – President...

2 months ago · zacks.com

QuidelOrtho (QDEL) Beats Q3 Earnings and Revenue Estimates

QuidelOrtho (QDEL) came out with quarterly earnings of $0.85 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.90 per share a year ago.

2 months ago · businesswire.com

QuidelOrtho to Participate in Three Upcoming Investor Conferences

3 months ago · businesswire.com

QuidelOrtho to Report Third Quarter 2024 Financial Results